Medical Oncology

Papers
(The H4-Index of Medical Oncology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Steps in metastasis: an updated review160
Exosomes and cancer: from molecular mechanisms to clinical applications51
An updated review of epidemiology, risk factors, and management of male breast cancer40
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review35
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors32
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia30
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?29
MicroRNAs and target molecules in bladder cancer26
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition25
Innovation in cancer therapeutics and regulatory perspectives24
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance24
PARP1-modulated chromatin remodeling is a new target for cancer treatment21
Cancer induced bone pain: current management and future perspectives21
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis21
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells21
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives20
De novo neuroendocrine transdifferentiation in primary prostate cancer–a phenotype associated with advanced clinico-pathologic features and aggressive outcome19
Vaccination of cancer patients against COVID-19: towards the end of a dilemma19
Organoid culture system for patient-derived lung metastatic osteosarcoma19
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer19
0.032500028610229